t-PA/PAI-1 complex expression correlates with the severity in hantaan virus-induced hemorrhagic fever with renal syndrome
Frontiers in Cellular and Infection Microbiology · 08.07.2026 · 16
DOI: 10.3389/fcimb.2026.1849586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 08.07.2026. Verfasst von Han-Dong Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory of Virology, Shaanxi Provincial Hospital of Infectious Diseases, The Xi'an Eighth Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Hemorrhagic Fever with Renal Syndrome, Hantaan virus. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives This study aimed to investigate t-PAIC concentration changes across severity levels in HFRS patients and evaluate its value in predicting disease severity, providing a potential biomarker for HFRS severity assessment and monitoring. Methods t-PAIC levels were measured by chemiluminescence immunoassay in 156 HFRS patients and 37 healthy controls. Routine laboratory tests assessed WBC, PLT, Cr, UA, urea, HDL, ALB, APTT, and PT. HFRS-specific antibodies were detected using the colloidal gold method. Spearman correlation analysis evaluated associations between t-PAIC and clinical indices. Ordinal logistic regression identified risk factors linked to disease severity. ROC curve analysis assessed the predictive performance of t-PAIC for HFRS severity. Results t-PAIC levels progressively increased with HFRS severity, peaking in critically ill patients. t-PAIC showed significant positive correlations with leukocyte count ( r = 0.6082; p < 0.01), Cr ( r = 0.3567; p < 0.01), urea ( r = 0.4376; p < 0.01), UA ( r = 0.3201; p < 0.01), APTT ( r = 0.6182; p < 0.01), and PT ( r = 0.2997; p < 0.01), and significant inverse correlations with PLT ( r = −0.6177; p < 0.01), HDL ( r = −0.3074; p < 0.01), and ALB ( r = −0.4790; p < 0.01). ROC analysis revealed t-PAIC had good predictive value for disease severity (AUC = 0.796, 95% CI : 0.724–0.867, p < 0.001). Conclusions t-PAIC levels closely reflect HFRS severity and associated clinical features, including renal dysfunction and coagulation abnormalities, suggesting its potential as a biomarker for monitoring disease status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory of Virology, Shaanxi Provincial Hospital of Infectious Diseases, The Xi'an Eighth Hospital, Xi'an, China.
- Clinical Laboratory Center, Shaanxi Provincial Hospital of Infectious Diseases, The Xi'an Eighth Hospital, Xi'an, China.
- Shaanxi Provincial Clinical Medical Research Center of Infectious Diseases, Shaanxi Provincial Hospital of Infectious Diseases, The Xi'an Eighth Hospital, Xi'an, China.
- Section of Science and Education, Shaanxi Provincial Hospital of Infectious Diseases, The Xi'an Eighth Hospital, Xi'an, China.
- Clinical Laboratory Center, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated Hospital of Northwest University, Xi'an, China.
Zitieren
APA
Zhao, H. D., Li, F. Y., Qian, H. B., Wang, P. L., Ma, K. X., & Liu, H. L. (2026). t-PA/PAI-1 complex expression correlates with the severity in hantaan virus-induced hemorrhagic fever with renal syndrome. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1849586
Vancouver
Zhao HD, Li FY, Qian HB, Wang PL, Ma KX, Liu HL. t-PA/PAI-1 complex expression correlates with the severity in hantaan virus-induced hemorrhagic fever with renal syndrome. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1849586
BibTeX
@article{Zhao2026,
author = {Zhao, Han-Dong and Li, Fei-Yu and Qian, Hong-Bo and Wang, Pei-Long and Ma, Kang-Xiao and Liu, Hong-Li},
title = {t-PA/PAI-1 complex expression correlates with the severity in hantaan virus-induced hemorrhagic fever with renal syndrome},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1849586}
}
EUVIMED